Novello, S., Torri, V., Grohé, C., Kurz, S., Serke, M., Wehler, T., . . . Scagliotti, G. V. (2022). Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66] : corrigendum. Annals of oncology, 33(4), . https://doi.org/10.1016/j.annonc.2022.01.005
Chicago-Zitierstil (17. Ausg.)Novello, Silvia, et al. "Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) Trial, a Phase III Multicenter Randomized Trial Comparing Adjuvant Pharmacogenomic-driven Chemotherapy Versus Standard Adjuvant Chemotherapy in Completely Resected Stage II-IIIA Non-small-cell Lung Cancer”: [Annals of Oncology 33 (2022) 57-66] : Corrigendum." Annals of Oncology 33, no. 4 (2022). https://doi.org/10.1016/j.annonc.2022.01.005.
MLA-Zitierstil (9. Ausg.)Novello, Silvia, et al. "Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) Trial, a Phase III Multicenter Randomized Trial Comparing Adjuvant Pharmacogenomic-driven Chemotherapy Versus Standard Adjuvant Chemotherapy in Completely Resected Stage II-IIIA Non-small-cell Lung Cancer”: [Annals of Oncology 33 (2022) 57-66] : Corrigendum." Annals of Oncology, vol. 33, no. 4, 2022, https://doi.org/10.1016/j.annonc.2022.01.005.